Strategic Assessment of HTS in the Asia Pacific Life Sciences Market
- Language: English
- Published: September 2003
- Your are here:
- Home
- Categories
- Pharmaceuticals and Healthcare
Strategic Analysis of the European High Throughput Screening (HTS) Market
Strategic Analysis of the European High Throughput Screening (HTS) Market
- Published: September 2004
- Frost & Sullivan
High Throughput Drug Screening - Allaying Risks Associated with Drug Discovery
The development of effective drugs remains a challenging, risky and expensive endeavour. High throughput drug screening (HTS) is emerging as a saviour in the field of drug discovery as pharmaceuticals and biotechnology companies compete to become the first to market new drugs. By shortening the drug discovery cycle, HTS offers the opportunity to capture the maximum market share and optimise revenue generation within the first year of entry. HTS also increases the chances of clearing clinical trials by addressing issues related to pharmacokinetics, animal toxicity and side effects. In spite of high equipment costs and poor quality of lead compounds presenting a significant challenge, HTS has the potential to yield both mechanistic insights and new drug leads with unparalleled efficiency through investment and innovation.
This Frost & Sullivan research evaluates the key drivers and challenges in the European HTS market. It also examines the important technology trends and provides strategic recommendations for designing high-impact action plans.
Outsourcing HTS to Custom
READ MORE >
<DIV style=MARGIN-TOP: 6px; MARGIN-LEFT: 10px>
1. Strategic Analysis of the European High Throughput Screening Market
- 1. Overview
- - 1. Overview
- 2. Research Scope & Methodology
- - 1. Research Scope & Methodology
- 3. Introduction & Background
- - 1. Introduction & Background
- 4. Market Dynamics
- - 1. Key Market Trends
- - 2. Market Drivers
- - 3. Market Restraints
- - 4. Industry Challenges
- - 5. Key Technology Trends
- - 6. Technology Drivers
- - 7. Technology Restraints
- 5. Total Market Forecasts
- - 1. Assumptions
- - 2. Total Revenue Forecasts
- - 3. Revenue Analysis
- - 4. Key Market Engineering Measurements
- - 5. Revenue Trends By Geographical Region
- - 6. Total Drug Development Expenditure
- - 7. Drug Discovery Market Share By Geographical Region
- - 8. Company Profiles
- 6. Strategic Analysis & Recommendations
- - 1. Market Maturation Process
- - 2. Strategic Anticipation
- - 3. Potential Threats
- - 4. Competitive Framework
- - 5. Market Potential
- - 6. Three Levels Of Strategies
- - 7. Pricing Strategy
- - 8. What Can Be Expected in the Future?
- - 9. Meeting the Challenge
- 7. Frost & Sullivan Awards
- - 1. Frost & Sullivan Awards
- - 2. Competitive Strategy Leadership Award
- - 3. Customer Service Innovation Award
- - 4. Market Leadership Award
- - 5. Technology Innovation Award
- - 6. Growth Strategy Leadership Award
- 8. Industry Participants
- - 1. Industry Participants
- 9. Decision Support Databases
- - 1. Decision Support Databases
- 10. Frost & Sullivan
- - 1. Healthcare Team
- - 2. Our Capabilities
| Format | Properties | |
|---|---|---|
| Site License | The report will be emailed to you. The report is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Site License | A copy of the report will be emailed to you and a printed copy will be shipped to you. The Electronic copy is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |
| Enterprisewide | A copy of the report will be emailed to you and a printed copy will be shipped to you. The Electronic copy is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |
Note: Product cover images may vary from those shown
RELATED PRODUCTS
-
FROM
-
U.S. High Throughput Screening Markets
- Language: English
- Published: September 2001
FROM -
European Cell Based Assays Markets
- Language: English
- 82 Pages
- Published: February 2008
- Region: Europe
FROM -
Overview of the European Drug Discovery Market
- Language: English
- 98 Pages
- Published: December 2008
- Region: Europe
FROM -
High Throughput Screening (HTS) - Global Strategic Business Report
- Language: English
- 629 Pages
- Published: March 2012
- Region: World
FROM -
Accelerating Lead Generation: Emerging Technologies and Strategies
- Language: English
- 161 Pages
- Published: June 2009
- Region: World
FROM -
The Drug Discovery Outsourcing Market
- Language: English
- 99 Pages
- Published: January 2011
- Region: World
FROM -
Superconductivity: The 7th Era and Coming Revolution in Power, Energy, Electronics, Computers, Communications, Transportation, Space and Beyond – Technologies, Applications, Markets, Competitors and Opportunities: 2011-2020 Analysis and Forecasts
Superconductivity: The 7th Era and Coming Revolution in Power, Energy, Electronics, Computers, Communications, Transportation, Space and Beyond – Technologies, Applications, Markets, Competitors and Opportunities: 2011-2020 Analysis and Forecasts
- Language: English
- Published: September 2011
- Region: World
FROM -
Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs
- Language: English
- 77 Pages
- Published: June 2011
- Region: World
FROM -
Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market
- Language: English
- 63 Pages
- Published: September 2012
- Region: World
FROM
